Samsung Becomes Largest Shareholder in U.S. Gene Analysis Firm, Expanding Healthcare Footprint

Samsung Electronics has invested an additional ~270 billion KRW into a U.S.-based genetic analysis equipment company, securing its position as the largest shareholder as it eyes the precision medicine market.